She Leads Biotech podcast

Brewing the Future of Medicine

0:00
36:39
Rewind 15 seconds
Fast Forward 15 seconds

What if the future of medicine could be brewed rather than manufactured through traditional processes?

In this episode of She Leads Biotech, I'm joined by Christina Smolke, Co-Founder & CEO, and Dr. Kristy Hawkins, Co-Founder & CSO of Antheia, to explore how they're using synthetic biology to transform pharmaceutical manufacturing.

From their beginnings as professor and graduate student at Caltech to co-founding a biotechnology company, Christina and Kristy share the story behind their remarkable partnership.

We discuss how Antheia uses engineered biology to produce essential medicines, why global pharmaceutical supply chains urgently need greater resilience, and what it takes to turn ambitious scientific research into commercial reality.

We also explore the challenges of fundraising, leading scientific teams, learning to delegate and persevering when others believe something simply cannot be done.

And perhaps most excitingly, we look at how this technology could create entirely new opportunities for drug discovery.

A fascinating conversation about innovation, persistence, leadership and the future of medicine.

🎧 Listen now to Brewing the Future of Medicine on She Leads Biotech.

#SheLeadsBiotech #WomenInBiotech #SyntheticBiology #Biomanufacturing #FutureOfMedicine

More episodes from "She Leads Biotech"